2021
Reported history and correlates of drug overdose among people who inject drugs in Lebanon
Khoshnood K, Sheb F, Khouri D, Aaraj E, Barbour R, Crawford F, Mokhbat J, Parpia A, Heimer R. Reported history and correlates of drug overdose among people who inject drugs in Lebanon. Eastern Mediterranean Health Journal 2021, 27: 571-579. DOI: 10.26719/2021.27.6.571.Peer-Reviewed Original ResearchSubstance use treatmentCorrelates of drugDrug overdoseOpioid overdoseDrug treatmentNon-fatal opioid overdoseUse treatmentOverdose prevention programsInfectious disease test resultsBetter epidemiologic dataDisease test resultsDrug use historySexual risk behaviorsHistory of incarcerationEffective treatment programsRespondent-driven samplingEligible PWIDDrug injectionEpidemiologic dataFirst drugAverage ageLebanese menHistory of arrestPrevention programsRisk behaviors
2020
Early Adoption of Dupilumab in the Medicare Population in 2017.
Cheraghlou S, Cohen JM. Early Adoption of Dupilumab in the Medicare Population in 2017. The Yale Journal Of Biology And Medicine 2020, 93: 675-677. PMID: 33380928, PMCID: PMC7757055.Peer-Reviewed Original ResearchConceptsAtopic dermatitisRural-Urban Continuum CodesMedicare populationHealth Statistics Urban-Rural Classification SchemeInjectable biologicsSevere atopic dermatitisRetrospective cohort studyCohort studyPatient outcomesDupilumabFirst drugMedicare Provider UtilizationFDA approvalUtilization trendsFirst FDAFuture interventionsProvider UtilizationPotential targetBiologicsDisease treatmentPatientsTreatmentFirst yearMore rural regionsContinuum Codes
2013
Intralesional collagenase in the treatment of Peyronie’s disease
Honig SC. Intralesional collagenase in the treatment of Peyronie’s disease. Therapeutic Advances In Urology 2013, 6: 47-53. PMID: 24688600, PMCID: PMC3943365, DOI: 10.1177/1756287213509849.Peer-Reviewed Original ResearchPeyronie's diseaseEvidence of efficacyMinimal side effectsUnited States FoodPharmacologic agentsFirst drugLarge dosesSide effectsDrug AdministrationDiseaseEuropean AssociationStates FoodSexual medicineTreatmentWound remodelingCollagenaseCurrent dataPharmacotherapyGradeVerapamilInterferonLocal effectsAgentsSteroidsAdministration
2004
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation
Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL, Investigators A. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation. Journal Of The American College Of Cardiology 2004, 43: 1201-1208. PMID: 15063430, DOI: 10.1016/j.jacc.2003.11.032.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channel BlockersCatheter AblationDigoxinDrug Therapy, CombinationElectrocardiography, AmbulatoryFemaleFollow-Up StudiesHeart RateHumansMaleMiddle AgedMultivariate AnalysisPacemaker, ArtificialStroke VolumeTreatment OutcomeConceptsCalcium channel blockersAtrial Fibrillation FollowAtrial fibrillationChannel blockersAFFIRM studyDrug classesFirst drugAdequate rate controlFirst drug classFrequent medication changesRhythm Management (AFFIRM) studyMajority of patientsBeta-adrenergic blockersRate control drugsElectrocardiographic resultsMedication changesWalk testInitial treatmentClinical variablesEfficacy criteriaDrug combinationsHeart rateEffective drugsPatientsMultivariate analysis
2000
Research Units on Pediatric Psychopharmacology (Rupp) Autism Network Background and Rationale for an Initial Controlled Study of Risperidone
McDougle C, Scahill L, McCracken J, Aman M, Tierney E, Arnold L, Freeman B, Martin A, McGough J, Cronin P, Posey D, Riddle M, Ritz L, Swiezy N, Vitiello B, Volkmar F, Votolato N, Walson P. Research Units on Pediatric Psychopharmacology (Rupp) Autism Network Background and Rationale for an Initial Controlled Study of Risperidone. Child And Adolescent Psychiatric Clinics Of North America 2000, 9: 201-224. PMID: 10674197, DOI: 10.1016/s1056-4993(18)30142-1.Peer-Reviewed Original ResearchConceptsOpen-label trialDA neuronal systemsSafety of risperidoneStudy of RisperidonePlacebo-controlled studyUse of risperidoneExtrapyramidal side effectsTarget of pharmacotherapyTreatment of childrenImpaired social behaviorLong-term effectivenessPreclinical evidenceReceptor blockadeTypical antipsychoticsControlled StudyFirst drugPathophysiology of autismLower riskShort-term benefitsSide effectsRisperidonePotent effectsSymptoms of autismNeuronal systemsEnhanced efficacy
1999
Treatment of Newly Diagnosed Pediatric Epilepsy: A Community-Based Study
Berg A, Levy S, Testa F, Shinnar S. Treatment of Newly Diagnosed Pediatric Epilepsy: A Community-Based Study. JAMA Pediatrics 1999, 153: 1267-1271. PMID: 10591304, DOI: 10.1001/archpedi.153.12.1267.Peer-Reviewed Original ResearchConceptsAntiepileptic drugsPediatric epilepsyInitial diagnosisIdiopathic localization-related epilepsyFirst antiepileptic drugTime of diagnosisTreatment of NewlyInitiation of treatmentLocalization-related epilepsySpecific seizure typesCommunity-based studyForms of epilepsyFrequency of treatmentDiagnosis of epilepsyFirst seizureSeizure typesUnprovoked seizuresSodium valproateSpecific medicationsCurrent guidelinesFirst drugInvestigational drugsEpilepsyMonths 90Specific drugs
1991
Trends of HIV-1 Risk Reduction among Initiates into Intravenous Drug Use 1982–1987
Vlahov D, Anthony J, Celentano D, Solomon L, Chowdhury N. Trends of HIV-1 Risk Reduction among Initiates into Intravenous Drug Use 1982–1987. The American Journal Of Drug And Alcohol Abuse 1991, 17: 39-48. PMID: 2038982, DOI: 10.3109/00952999108992808.Peer-Reviewed Original ResearchConceptsIntravenous drug usersFirst injectionHIV-1 risk reductionActive intravenous drug usersCross-sectional interview studyNew sterile needlesNeedle-sharing partnersFrequency of injectionsLow-risk practicesSelf-administered drugsFirst drugInjection practicesSterile needleDrug usersInitial injectionAIDS epidemicRisk practicesCocaine epidemicInjectionRisk reductionMantel-Haenszel statisticsHeroinSuccessive cohortsCocaineDrugs
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply